The present results suggest that the improvements in spatial memory observed after ICVIGF-1 administration in the sAD model may also be attributed to IGF-1-induced reductions in anhedonia and anxiety and peripheral anti-inflammatory effects. The gene discussed is IGF1; the disease is Anxiety.